Co's stock has reached a 52-week low, dipping to $85.71. This downturn reflects a significant shift from the previous year, with the pharmaceutical giant experiencing a 1-year change of -31.59%.

The Senate is expected to clear a procedural hurdle Wednesday to approve Robert F. Kennedy Jr. as Health and Human Services ...

Neuphoria Therapeutics said it expects to receive a milestone payment from Merck for the second clinical trial phase of its Alzheimer's disease dementia treatment.

The German drugmaker confirmed acquisition talks, but cautioned a deal may not materialize. Elsewhere, Biohaven got priority ...

Artificial intelligence could be used to prescribe medications to patients — if a new bill makes its way through Congress ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...

A guide to the people and activist organizations who paved the way for Donald Trump's attacks on diversity practices in ...

As secretary of the HHS, Kennedy would oversee major health agencies, including the Food and Drug Administration (FDA), the ...

White House press secretary Karoline Leavitt said President Donald Trump still plans to implement 25 percent tariffs on ...

Robert F. Kennedy Jr., President Trump’s nominee for Health and Human Services secretary, told senators Friday he will divest his financial stake in a lawsuit against pharmaceutical giant Merck over ...

You know these ads. They generally include someone barely making their way through the day; then suddenly, as if by magic, the world goes from black and white to color. A previously ill person can ...

The recent Senate confirmation hearings for Robert F. Kennedy Jr. presented a striking scene that would confuse a time ...